We are live on ! Find out more
COCH icon

Envoy Medical

89 hedge funds and large institutions have $331M invested in Envoy Medical in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

67% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 9

6% more funds holding

Funds holding: 8489 (+5)

3.61% more ownership

Funds ownership: 76.99%80.61% (+3.6%)

4% more capital invested

Capital invested by funds: $319M → $331M (+$11.5M)

Holders
89
Holders Change
+5
Holders Change %
+5.95%
% of All Funds
1.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
15
Reduced
9
Closed
4
Calls
Puts
Net Calls
Net Calls Change

COCH Hedge Fund Activity: Q2 2022 in Review

89 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q2 2022, worth a combined $331M — up 3.6% from $319M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new COCH positions and 4 closed out — a net gain of 5 holders — while 15 added to existing stakes and 9 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $4.61M. The largest seller was EMG Holdings, exiting entirely with an estimated $2.18M sold.

  • 89 institutional investors held Envoy Medical (COCH) as of Q2 2022, up from 84 in Q1 2022.
  • Funds reported $331M of Envoy Medical stock for Q2 2022, up 3.6% quarter-over-quarter.
  • 9 funds opened new Envoy Medical positions in Q2 2022 and 4 closed out, a net change of +5 holders.
  • The largest Envoy Medical buyer in Q2 2022 was UBS O'Connor, an estimated $4.61M added.
  • The largest Envoy Medical seller in Q2 2022 was EMG Holdings, an estimated $2.18M sold.

Based on aggregated 13F filings for Q2 2022.